Applications Invited for Precision Biotherapeutics-Cell and Gene Therapy for Fostering High Performance Biomanufacturing under BioE3 Policy

Follow us@ngobox

About the Organization

Biotechnology Industry Research Assistance Council (BIRAC) is a not-for-profit Section 8, Schedule B, Public Sector Enterprise, set up by Department of Biotechnology (DBT), Government of India as an Interface Agency to strengthen and empower the emerging Biotech enterprise to undertake strategic research and innovation, addressing nationally relevant product development needs.

BIRAC is a industry-academia interface and implements its mandate through a wide range of impact initiatives, be it providing access to risk capital through targeted funding, technology transfer, IP management and handholding schemes that help bring innovation excellence to the biotech firms and make them globally competitive. In its Eight years of existence, BIRAC has initiated several schemes, networks and platforms that help to bridge the existing gaps in the industry-academia Innovation research and facilitate novel, high quality affordable products development through cutting edge technologies. BIRAC has initiated partnerships with several national and global partners to collaborate and deliver the salient features of its mandate.

About the Grant  

Cell and Gene Therapy (CGT) has been identified as one of the priority areas under the ‘Precision Biotherapeutics’ vertical of the BioE3 Policy for ‘fostering high performance Biomanufacturing’. The CGT sector is a rapidly evolving field with transformative potential for treatment of a range of complex and previously untreatable diseases. The potential of this emerging therapeutic modality is highlighted by the increasing number of CGTs which have been approved and are also in the development pipeline. DBT and BIRAC aim to foster an innovation ecosystem for enabling the development of novel CGTs with an emphasis on improving clinical outcomes, enhancing safety, and advancing translational applications in the field. In view of this, DBT and BIRAC invite proposals on “Precision Biotherapeutics-Cell and Gene Therapy”, with the objective to build requisite capabilities and create necessary infrastructure for advancing this field through novel approaches/ technologies, and enabling development of a pipeline of indigenous and affordable CGT candidates.

The proposals are invited under two categories where first category i.e. “Discovery and application oriented Integrated Network research” focuses on demonstration of “Proof -of-concept” and early stage validation (TRL: 3-5) and second category i.e. “Bridging the gaps for scale-up” focuses on early and late-stage development of CGT candidates (TRL: 5-7)

Eligibility

• Companies established under the Companies Act 2013 and Startups
• The Limited Liability Partnership (LLP) incorporated under the Limited Liability Partnership Act,2008
• Academic from various Institutions/Universities/Societies/ Trusts/NGOs/Foundations/ Voluntary Organizations, recognized as a Scientific and Industrial Research Organization (SIRO).

How to Apply

Proposals for the Scheme is required to be submitted online only. To submit a proposal online, please log on to the BIRAC website (www.birac.nic.in).

No Hard Copy to be submitted. Proposals submitted online only would be considered.

Last date for Submission of Proposals: 15th March 2025 (midnight)

For more information please check the Link

Stay in the loop with the newest RFPs and Grants through NGOBOX's WhatsApp Channel. Join now by clicking here!

Tags Healthcare and Healthtech Research Others